Literature DB >> 4113389

Sulfation factor (somatomedin): an explanation for continued growth in the absence of immunoassayable growth hormone in patients with hypothalamic tumors.

J W Finkelstein, J Kream, A Ludan, L Hellman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4113389     DOI： 10.1210/jcem-35-1-13

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Effect of administered human growth hormone on growth retardation in inflammatory bowel disease.

Authors:  T D McCaffery; K Nasr; A M Lawrence; J B Kirsner
Journal:  Am J Dig Dis       Date:  1974-05

Review 2.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

3.  Long-term follow-up of children with craniopharyngioma.

Authors:  N Stahnke; G Grubel; I Lagenstein; R P Willig
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

4.  Endocrine function, morbidity, and mortality after surgery for craniopharyngioma.

Authors:  K R Lyen; D B Grant
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

5.  Pre- and postoperative evaluation of hypothalamo- pituitary function in children with craniopharyngiomas.

Authors:  W Andler; K Roosen; H E Clar
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.